Mano Michael (CIK 1837741) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-15). Recent activity: Buy KPTI (700 shares), Sell KPTI (266 shares), Sell KPTI (3,526 shares), Buy KPTI (32,415 shares), Buy KPTI (43,650 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP, CLO&Secretary | Buy | 700 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP, CLO&Secretary | Sell | 266 | $2,527 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP, CLO&Secretary | Sell | 3,526 | $33,180 |
| 2026-02-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP, CLO&Secretary | Buy | 32,415 | $0 |
| 2025-10-16 | Karyopharm Therapeutics Inc. (KPTI) | SVP, General Counsel&Secretary | Buy | 43,650 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | SVP, General Counsel&Secretary | Buy | 612 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | SVP, General Counsel&Secretary | Sell | 234 | $1,505 |
| 2025-03-06 | Karyopharm Therapeutics Inc. (KPTI) | SVP, General Counsel&Secretary | Sell | 2,793 | $17,568 |
| 2025-03-04 | Karyopharm Therapeutics Inc. (KPTI) | SVP, General Counsel&Secretary | Buy | 3,333 | $0 |
| 2025-03-04 | Karyopharm Therapeutics Inc. (KPTI) | SVP, General Counsel&Secretary | Buy | 2,250 | $0 |
Source: SEC Form 4 filings · as of 2026-05-15